Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRP.L Regulatory News (PRP)

  • There is currently no data for PRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

15 Apr 2020 07:00

RNS Number : 6443J
Prime People PLC
15 April 2020
 

 

15 April 2020

 

Prime People plc

("Prime People" or the "Company")

 

COVID-19 Update

 

Prime People (AIM: PRP), the global specialist recruitment business for professional and technical staff working in the Real Estate & Built Environment, Energy & Environmental and Technology, Digital & Data Analytics sectors, announces the following update on trading, in light of COVID-19.

 

The health and safety of our employees, clients and candidates is of paramount importance to us. The majority of our global workforce are currently working from home. Our cloud-based platforms have allowed full business continuity and our people have been able to service clients throughout this unpredictable period.

 

As a direct result of COVID-19, we have now experienced a significant reduction in demand across our businesses with the impact varying considerably by location and sector. We have taken early action to implement a range of measures to protect our business from the financial impact of COVID-19. These include:

 

· Managing our staff costs through furlough, reductions in headcount, reduced hours and reductions in remuneration primarily in the UK. As at the date of this announcement, approximately 40% of our UK workforce are on furlough;

· Ensuring all relevant available governmental employment protection schemes are utilised for relevant employees in our international locations;

· Minimising discretionary spend and driving reductions in all operational expenditure to align with anticipated levels of business;

· Stalling planned capital expenditure and organic and non-organic growth plans; and

· Rigorous cash flow management including taking action to reduce cash outflow by the deferral of tax payments to tax authorities, where available.

 

Our present focus is on cash management and matching expenditure to likely levels of business, and implementing certain measures to ensure that we are in a position to accelerate activity when markets improve. With that in mind, in order to strengthen the balance sheet and aid liquidity, the Board does not anticipate paying a final dividend for the year ending 31 March 2020. The Board remains committed to paying progressive dividends as soon as appropriate and when there is better clarity on the financial consequences of COVID-19.

 

Peter Moore, Chief Executive Officer, commented:

 

"I would like to thank our team for their unfailing support, understanding, hard work and resilience in unprecedented times. Our historic investments in technology have meant that we are able to continue to work and communicate effectively with our clients and candidates remotely. The Group has a very experienced management team and expects that it will be in a solid position to take rapid advantage of market opportunities when they materialise".

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact: 

 

Prime People

Robert Macdonald, Executive Chairman

020 7318 1785

Donka Zaneva-Todorinski, Finance Director

Cenkos Securities plc

020 7397 8900

Katy Birkin/Nick Wells/Harry Hargreaves

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKQBKOBKDCQD
Date   Source Headline
24th Jan 20227:00 amRNSSecondary Trading following Cancellation
18th Jan 20225:30 pmRNSPrime People
17th Jan 20222:03 pmRNSResult of Tender Offer
12th Jan 202212:39 pmRNSResult of General Meeting and Cancellation
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSProposed Cancellation and Tender Offer
19th Nov 20217:00 amRNSHalf-year Report
1st Sep 20213:26 pmRNSResult of AGM
4th Aug 20213:35 pmRNSPosting of Annual Report and Notice of AGM
23rd Jul 20217:00 amRNSFinal Results
28th May 20211:05 pmRNSExercise of Options and Transaction in Own Shares
24th May 20211:44 pmRNSExercise of Options and Transaction in Own Shares
1st Apr 20217:00 amRNSDirectorate Change
25th Feb 20219:20 amRNSBoard Change
29th Jan 20217:00 amRNSHalf-year Report
29th Dec 202010:30 amRNSGrant of Options
22nd Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20202:38 pmRNSTransaction in Own Shares
23rd Nov 20201:49 pmRNSResult of General Meeting
10th Nov 20207:00 amRNSShare Buyback Programme and Interims Extension
4th Nov 202011:12 amRNSFinal Results
22nd Sep 20203:43 pmRNSResult of AGM
22nd Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20207:00 amRNSIntention to purchase own shares
10th Sep 20207:00 amRNSPre-Close Trading Update
24th Aug 20207:00 amRNSNotice of AGM, Results & Accounts Extension
12th Jun 20201:12 pmRNSNew Banking Facility
15th Apr 20207:00 amRNSCOVID-19 Update
4th Feb 20203:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSDirectorate Change
21st Jan 20201:00 pmRNSResult of Court Hearing
10th Jan 20204:41 pmRNSExercise of Options and Issue of Equity
8th Jan 20205:11 pmRNSExercise of Options and PDMR Shareholding
3rd Jan 202012:24 pmRNSResult of General Meeting
2nd Jan 20201:30 pmRNSPDMR Shareholding and Treasury Shares
23rd Dec 201912:20 pmRNSExercise of Options and PDMR Shareholding
19th Dec 20199:29 amRNSDirector/PDMR Shareholding
18th Dec 20197:00 amRNSProposed Return of Capital
5th Dec 201910:41 amRNSExercise of Options and Transaction in Own Shares
14th Nov 20197:00 amRNSHalf-year Report
27th Sep 201911:11 amRNSExercise of Options and Transaction in Own Shares
4th Sep 20194:10 pmRNSTransaction in Own Shares
2nd Sep 20193:04 pmRNSDirector/PDMR Shareholding
21st Aug 20191:52 pmRNSExercise of Options and Transaction in Own Shares
12th Aug 20192:20 pmRNSExercise of Options and PDMR Shareholding
24th Jul 201912:26 pmRNSResult of AGM
21st Jun 20197:00 amRNSFinal Results
29th Apr 20194:05 pmRNSDirector/PDMR Shareholding
5th Mar 20194:06 pmRNSTransaction in Own Shares and PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.